Trump's Terms
White House orders NIH to research trans 'regret' and 'detransition'
Apr 11, 2025
The podcast delves into the controversial directive from the Trump administration ordering the NIH to study gender transition effects, including regret and detransition. Researchers and LGBTQ advocates discuss the implications for public health and rights. It also highlights the surprisingly low rates of regret in gender-affirming care, raising concerns about the impact of reduced funding on transgender health research. The complexities surrounding regret in transition-related healthcare form a crucial part of the conversation.
05:11
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The Trump administration's directive for NIH research into gender transition regret raises significant concerns about the political motivations behind scientific inquiry.
- Critics argue that the emphasis on regret and detransition disregards existing evidence of low regret rates in individuals who undergo gender-affirming care.
Deep dives
NIH Study on Gender Transition Effects
The National Institutes of Health (NIH) has been directed to investigate the physical and mental health effects of gender transition, focusing particularly on children. This initiative raises concerns among researchers and the LGBTQ community, as the terminology used in the directive, such as 'chemical and surgical mutilation,' is considered offensive and stigmatizing. Critics like Adrian Schenker emphasize that the language undermines scientific integrity, suggesting the study seeks political answers rather than evidence-based conclusions. Many believe the emphasis on regret and detransition overlooks the substantial evidence indicating low rates of regret following gender-affirming care.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
